A researcher works on a sample of the new coronavirus inside a secure laboratory in microbiology and immunology at the University of Maryland School of Medicine. (Robert Haupt/University of Maryland School of Medicine)

The mounting toll of coronavirus deaths, involving health-care workers on the front lines of the disease and older people in hospitals, raises a basic question: How does the new virus make people sick, and why does it kill some of them?

No one knows exactly how or why the novel coronavirus leads to death in just a small percentage of patients — about 2 percent of those infected, according to preliminary numbers. Based on what we know about related illnesses, including severe acute respiratory syndrome (SARS), experts hypothesize that the difference between a lethal infection and one that feels like a bad cold probably hinges on the interaction between the virus and a person’s immune system.

Live updates: Coronavirus cases surge in South Korea as first death reported; mayor tells residents to stay indoors

While the virus attacks and kills cells in all cases, serious illness will depend on how the immune system responds, and that can be influenced by age, gender, genetics and underlying medical conditions. The initial damage caused by the virus can trigger a powerful and counterproductive overreaction by the immune system itself.

As of early March, people have tested positive for the coronavirus in about 70 countries. Officials are taking "unprecedented" actions. (Video: The Washington Post)

“What you get is the initial damage and rush of inflammatory cells, but the damage is so extensive that the body’s immune response is completely overwhelmed — which causes even more immune response, more immune cells and more damage,” said Matthew Frieman, a virologist at the University of Maryland School of Medicine.

Inside a lab where scientists are working urgently to fight the coronavirus outbreak

The coronavirus is spread when an infected person sneezes or coughs, spraying droplets through the air. The sick person might sneeze directly in another person’s face or expel droplets widely, contaminating surfaces that healthy people touch before unknowingly spreading germs to their mouths or noses. Health-care workers are at especially high risk because they are exposed to very high doses of the virus and also perform procedures — such as putting patients on ventilators to help them breathe — that can spread it.

With infection, the virus probably begins to multiply inside cells lining the airway, which are fringed with hairlike structures. Coronaviruses that cause common colds are excellent at infecting the upper airway, while SARS tended to go deeper in the lungs. As the coronavirus gains strength, Frieman said, dead cells are sloughed off and collect in the airway, making breathing difficult.

“If the virus replicates very quickly, before your body has a chance to try and prevent it with an immune response, or if the immune response comes in too late, then it can’t control the virus and starts going berserk,” said Anthony Fehr, a virologist at the University of Kansas.

This is what scientists refer to as a “cytokine storm,” which causes the immune system to start sending cells ready to do battle into the lung. At that point, it’s not just the virus doing damage to the body; the immune system begins wreaking havoc on the infected person — also known as the “host” in medical parlance.

“The experience with other respiratory viruses would suggest it is a combination of the virus doing damage to the airways, secondary infections and the interplay with the host immune response,” said Erica S. Shenoy, an infectious diseases specialist at Massachusetts General Hospital.

Coronavirus vaccine research is moving at record speed

The general risk factors for this mismatch between the immune system and any respiratory illness include advanced age and underlying chronic illnesses, including diabetes and high blood pressure, though public health experts are eager to understand more about who is most vulnerable in the current outbreak.

“Every individual is different,” Fehr said, and there are differences in how young and old or male and female immune systems react. “There are lots of dynamics at play when you talk about each individual and how they might die from this virus or why they might survive.”

Problems can also stack up. Vineet Menachery, a virologist at the University of Texas Medical Branch, suspects that the coronavirus may work much like SARS. When the virus gets deep into the lungs, it can damage alveoli, the air sacs that take in oxygen. As cellular damage accumulates, lung tissue begins to stiffen. The heart must work harder to get limited oxygen to the rest of the organs.

“What makes this new virus so damaging is you’re losing lung function, and that puts a strain on every organ in your body,” Menachery said.

In the patients who recover, the immune system’s response has worked: It has cleared the virus, with inflammation receding. Yet experts don’t know the long-term outcome for these individuals. It’s possible they will gain immunity and be protected from reinfection. Or they might get a less severe case in the future — or not be protected at all. They also might just gain temporary immunity. It’s yet another unanswered question about the coronavirus.

Coronavirus: What you need to know

End of the public health emergency: The Biden administration ended the public health emergency for the coronavirus pandemic on May 11, just days after WHO said it would no longer classify the coronavirus pandemic as a public health emergency. Here’s what the end of the covid public health emergency means for you.

Tracking covid cases, deaths: Covid-19 was the fourth leading cause of death in the United States last year with covid deaths dropping 47 percent between 2021 and 2022. See the latest covid numbers in the U.S. and across the world.

The latest on coronavirus boosters: The FDA cleared the way for people who are at least 65 or immune-compromised to receive a second updated booster shot for the coronavirus. Here’s who should get the second covid booster and when.

New covid variant: A new coronavirus subvariant, XBB. 1.16, has been designated as a “variant under monitoring” by the World Health Organization. The latest omicron offshoot is particularly prevalent in India. Here’s what you need to know about Arcturus.

Would we shut down again? What will the United States do the next time a deadly virus comes knocking on the door?

For the latest news, sign up for our free newsletter.